Catalogue of analyzed articles
All articles evaluated by Publi-Score, with their score and details.
Loading...
All articles evaluated by Publi-Score, with their score and details.
182 articles found— page 1/19
ISRCTN63917405.
…o moderate effect sizes). Distinction between passive vs active use is important. Causal direction remains unclear as most underlying studies are cross-sectional. Calls for standardized measures and longitudinal designs.
…1). No significant differences were observed in ADCS-ADL or CDR-SoB scores. Liraglutide was generally safe and well tolerated in non-diabetic patients with Alzheimer's disease. ClinicalTrials.gov identifier: NCT01843075.
…y outcomes: incidence of 14 cancers. GLP-1RAs associated with lower overall cancer risk (HR 0.83; 95% CI 0.76–0.91; P=0.002). Significant reductions for endometrial (HR 0.75), ovarian (HR 0.53), and meningioma (HR 0.69).
…ignificantly greater %WC on MPF (Δ%WC, −1.01 [95% CI −1.87, −0.14], P=0.024; Cohen's d, −0.48). Mild gastrointestinal adverse events were common on both diets. Findings indicate greater weight loss on MPF than UPF diets.
…ged organs progressively increased mortality risk (2-4 aged organs HR=2.3; 5-7 HR=4.5; 8+ HR=8.3), whereas youthful brains and immune systems were uniquely associated with longevity (youthful both HR=0.44 for mortality).
… inflammatory response and risk of post-operative infections. These findings indicate that fat emulsion-based early parenteral nutrition enhances short-term post-operative recovery in patients undergoing hemihepatectomy.
… insulin: significant risk reduction in 10 of 13 OACs including gallbladder cancer (HR 0.35), meningioma (HR 0.37), pancreatic cancer (HR 0.41). GLP-1RAs vs metformin: mostly non-significant. Erratum published June 2025.
… stroke) occurred in 6.5% in the semaglutide group vs 8.0% in the placebo group (HR 0.80, 95% CI 0.72–0.90, P<0.001). Adverse events leading to permanent discontinuation occurred in 16.6% (semaglutide) vs 8.2% (placebo).
… plantarum 299V. Very low certainty for most other combinations. Certainty of evidence by GRADE was low to very low across almost all analyses. Some combinations may be beneficial but firm recommendations cannot be made.
Summary scores
44
Average score
49
Median score
Tier distribution
Temporal trend